Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371176 · ClinicalTrials.gov registry record · NA
A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT00371176 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 26 participants.
The verdict
NCT00371176, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The primary aim of this project is to examine whether administration of D-Cycloserine (DCS), a partial N-methyl-D-aspartate (NMDA) receptor agonist that has been shown to facilitate fear extinction, enhances the therapeutic benefit of exposure-based cognitive behavioral therapy (CBT) in OEF/OIF veterans with PTSD.
Interventions
- BEHAVIORAL Exposure therapy
- OTHER Placebo pill
- DRUG D-Cycloserine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-10 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00371176
The ClinicalTrials.gov registry entry for NCT00371176 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Exposure therapy is the first listed.
NCT00371176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00371176 about?
NCT00371176 is a clinical study titled "A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD". The primary aim of this project is to examine whether administration of D-Cycloserine (DCS), a partial N-methyl-D-aspartate (NMDA) receptor agonist that has been shown to facilitate fear extinction, enhances the therapeutic benefit of exposure-based cognitive behavioral therapy (CBT) in OEF/OIF vete...
What is the current status of trial NCT00371176?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2006-10. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00371176?
The interventions under investigation include: Exposure therapy (BEHAVIORAL), Placebo pill (OTHER), D-Cycloserine (DRUG).
Who is sponsoring clinical trial NCT00371176?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.